SHUKRAPHAR
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited (SHUKRAPHAR) financial statements and selected valuation metrics through 30 September 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-11-04
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
Company snapshot
69thBy market cap
Ranked among 120 companies in Pharmaceuticals.
Segment mix
Reportable segments as of 2026-09-30 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 83.2% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Pharamaceutical segment | 83.2% | 56 Cr | 34 Cr | 0.24 Cr |
| Medtech segment | 18.5% | 13 Cr | 3 Cr | 14 Cr |
Shares add up to 102% because segment revenues are before inter-segment eliminations.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2026 |
|---|---|
| Sales | 44 Cr |
| Operating expenses (approx.) | 25 Cr |
| EBITDA | 19 Cr |
| OPM % | 42.3% |
| Other income | 0.57 Cr |
| Interest | 0.33 Cr |
| Depreciation | 1 Cr |
| Profit before tax | 18 Cr |
| Tax % | 28.7% |
| Net profit | 13 Cr |
| EPS (₹) | ₹0.29 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | TTM |
|---|---|
| Sales | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | Sign in free for the trailing twelve months |
| EBITDA | Sign in free for the trailing twelve months |
| OPM % | Sign in free for the trailing twelve months |
| Other income | Sign in free for the trailing twelve months |
| Interest | Sign in free for the trailing twelve months |
| Depreciation | Sign in free for the trailing twelve months |
| Profit before tax | Sign in free for the trailing twelve months |
| Tax % | Sign in free for the trailing twelve months |
| Net profit | Sign in free for the trailing twelve months |
| EPS (₹) | Sign in free for the trailing twelve months |
| Dividend payout % | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
No data for this view.
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
No data for this view.
Ratios
No data for this view.